Sutro Biopharma (STRO) Shares Outstanding (2017 - 2025)

Sutro Biopharma (STRO) has 8 years of Shares Outstanding (Entity) data on file, last reported at $8.6 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Entity) rose 4.02% year-over-year to $8.6 million; the trailing twelve-month figure through Dec 2025 stood at $8.6 million (up 4.02% YoY), and the FY2025 full-year result was $8.6 million, up 4.02% from the prior year.
• Shares Outstanding (Entity) grew to $8.6 million in Q4 2025, from $8.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $8.6 million in Q4 2025 to a low of $4.6 million in Q1 2021.
• A 5-year average of $6.4 million and a median of $6.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 98.49% in 2021 and increased 1.79% in 2022, its largest moves.
• Tracing STRO's Shares Outstanding (Entity) over 5 years: stood at $4.6 million in 2021, then grew by 24.12% to $5.7 million in 2022, then grew by 6.1% to $6.1 million in 2023, then soared by 35.27% to $8.3 million in 2024, then advanced by 4.02% to $8.6 million in 2025.
• Business Quant data shows STRO's Shares Outstanding (Entity) at $8.6 million in Q4 2025, $8.5 million in Q3 2025, and $8.5 million in Q2 2025.